The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.
The RING Domain of Mdm2 Mediates Histone Ubiquitylation and Transcriptional Repression
Open accessAbstract
Histone modifications play a pivotal role in regulating transcription and other chromatin-associated processes. In yeast, histone H2B monoubiquitylation affects gene silencing. However, mammalian histone ubiquitylation remains poorly understood. We report that the Mdm2 oncoprotein, a RING domain E3 ubiquitin ligase known to ubiquitylate the p53 tumor suppressor protein, can interact directly with histones and promote in vitro monoubiquitylation of histones H2A and H2B. Moreover, Mdm2 induces H2B monoubiquitylation in vivo. Endogenous Mdm2 is tethered in vivo, presumably via p53, to chromatin comprising the p53-responsive p21(waf1) promoter, and Mdm2 overexpression enhances protein ubiquitylation in the vicinity of a p53 binding site within that promoter. Moreover, when recruited to a promoter in the absence of p53, Mdm2 can repress transcription dependently on its RING domain, suggesting that its E3 activity contributes to repression. Histone ubiquitylation may thus constitute a novel mechanism of transcriptional repression by Mdm2, possibly underlying some of its oncogenic activities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, Mdm2 can transcriptionally inactivate some p53 target genes by direct ubiquitylation of histones [109].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [109]
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Live or let die: the cell's response to p53
Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,231
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,231
Histone modifications in transcriptional regulation
Berger, S. L. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00279-4 · Cited by 1,222
Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast
Sun, Z., & Allis, C. D. (2002) · Nature · doi:10.1038/nature00883 · Cited by 1,076
Flagged first, then by citations
2 of the 54 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N. B.-C., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,365
Self-citationShilatifard, A. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051710-134100 · Cited by 1,091
Acetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
Histone Ubiquitination: Triggering Gene Activity
Weake, V. M., & Workman, J. L. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.014 · Cited by 719
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
Monoubiquitination of Human Histone H2B: The Factors Involved and Their Roles in HOX Gene Regulation
Zhu, B., Zheng, Y., Pham, A.-D., Mandal, S. S., Erdjument‐Bromage, H., Tempst, P., & Reinberg, D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.09.025 · Cited by 554
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
Zhou, W., Zhu, P., Wang, J., Pascual, G., Ohgi, K. A., Lozach, J., Glass, C. K., & Rosenfeld, M. G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.11.002 · Cited by 407
Minsky, N., Shema, E., Field, Y., Schuster, M., Segal, E., & Oren, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1712 · Cited by 390
Self-citationMdm2-mediated ubiquitylation: p53 and beyond
Marine, J.-C., & Lozano, G. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.68 · Cited by 354
Shema, E., Tirosh, I., Aylon, Y., Huang, J. L., Ye, C., Moskovits, N. B.-C., Raver-Shapira, N., Minsky, N., Pirngruber, J., Tarcic, G., et al. (2008) · Genes & Development · doi:10.1101/gad.1703008 · Cited by 290
Self-citationA positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidizationPreprint
Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H., & Oren, M. (2006) · Genes & Development · doi:10.1101/gad.1447006 · Cited by 287
Self-citationDisulfide-directed histone ubiquitylation reveals plasticity in hDot1L activation
Chatterjee, C., McGinty, R. K., Fierz, B., & Muir, T. W. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.315 · Cited by 249
Karagianni, P., Amazit, L., Qin, J., & Wong, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01598-07 · Cited by 260
Itahana, K., Mao, H., Jin, A., Itahana, Y., Clegg, H. V., Lindström, M. S., Bhat, K. P., Godfrey, V. L., Evan, G. I., & Zhang, Y. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.09.007 · Cited by 245
Surf the Post-translational Modification Network of p53 Regulation
Gu, B., & Zhu, W. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4283 · Cited by 252
Marine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228
Shi, D., & Gu, W. J. (2012) · Genes & Cancer · doi:10.1177/1947601912455199 · Cited by 220
Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2
Ferreon, J. C., Lee, C. W., Arai, M., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811023106 · Cited by 210
The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73
Levy, D., Adamovich, Y., Reuven, N. B., & Shaul, Y. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402063 · Cited by 215
Complicating the complexity of p53
Yee, K. S. Y., & Vousden, K. H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi122 · Cited by 190
Brooks, C. L., & Gu, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.022 · Cited by 186
hCAS/CSE1L Associates with Chromatin and Regulates Expression of Select p53 Target Genes
Tanaka, T., Ohkubo, S., Tatsuno, I., & Prives, C. L. (2007) · Cell · doi:10.1016/j.cell.2007.08.001 · Cited by 173
BBAP Monoubiquitylates Histone H4 at Lysine 91 and Selectively Modulates the DNA Damage Response
Yan, Q., Dutt, S., Xu, R., Graves, K., Juszczyński, P., Manis, J. P., & Shipp, M. A. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.08.019 · Cited by 171
Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis
Lee, E., Lee, M.-S., Camus, S., Ghim, J., Yang, M. R., Oh, W., Ha, N., Lane, D. P., & Song, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.164 · Cited by 162
Ubiquitin‐specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor
Maertens, G. N., Messaoudi, S. E., Elderkin, S., Hiom, K. J., & Peters, G. G. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.129 · Cited by 162
Chao, C. C. ‐. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.015 · Cited by 155
MOZ increases p53 acetylation and premature senescence through its complex formation with PML
Rokudai, S., Laptenko, O., Arnal, S. M., Taya, Y., Kitabayashi, I., & Prives, C. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300490110 · Cited by 165
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
Wang, W., Albadari, N. G., Du, Y., Fowler, J. F., Sang, H. T., Xian, W., McKeon, F., Li, W., Zhou, J., & Zhang, R. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001026 · Cited by 151
Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway
Zhang, Z., Wang, H., Li, M., Rayburn, E. R., Agrawal, S., & Zhang, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208814 · Cited by 139
Daou, S., Hammond-Martel, I., Mashtalir, N., Barbour, H., Gagnon, J. K., Iannantuono, N., Nkwe, N. S., Motorina, A., Pak, H., Yu, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.661553 · Cited by 145
Writing and reading H2B monoubiquitylation
Fuchs, G., & Oren, M. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.01.002 · Cited by 135
Self-citationHistone H2B monoubiquitination: roles to play in human malignancy
Cole, A. J., Clifton-Bligh, R. J., & Marsh, D. J. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0185 · Cited by 136
New insights into p53 activation
Brooks, C. L., & Gu, W. (2010) · Cell Research · doi:10.1038/cr.2010.53 · Cited by 102
MDM2 and MDMX: Alone and together in regulation of p53.
Shadfan, M., Lopez-Pajares, V., & Yuan, Z.-M. (2012) · PubMed · Cited by 125
Deng, Z., Cao, P. D., Wan, M., & Sui, G. (2010) · Transcription · doi:10.4161/trns.1.2.12375 · Cited by 127
Arva, N. C., Gopen, T., Talbott, K. E., Campbell, L. E., Chicas, A., White, D. E., Bond, G. L., Levine, A. J., & Bargonetti, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505203200 · Cited by 122
Ablation of Key Oncogenic Pathways by RITA-Reactivated p53 Is Required for Efficient Apoptosis
Grinkevich, V. V., Nikulenkov, F., Shi, Y., Enge, M., Bao, W., Malyukova, A., Gluch, A., Kel, A. E., Sangfelt, O., & Selivanova, G. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.021 · Cited by 118
Sarkari, F., Sanchez-Alcaraz, T., Wang, S., Holowaty, M. N., Sheng, Y., & Frappier, L. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000624 · Cited by 118
Wienken, M., Dickmanns, A., Nemajerová, A., Kramer, D., Najafova, Z., Weiss, M., Karpiuk, O., Kassem, M. S., Zhang, Y., Lozano, G., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.12.008 · Cited by 116
Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53
Arena, G., Cissé, M. Y., Pyrdziak, S., Châtre, L., Riscal, R., Fuentes, M., Arnold, J. J., Kastner, M., Gayte, L., Bertrand‐Gaday, C., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.023 · Cited by 109
Meisetz and the birth of the KRAB motif
Birtle, Z., & Ponting, C. P. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl498 · Cited by 107
Targeting epigenetic enzymes for drug discovery
Copeland, R. A., Olhava, E. J., & Scott, M. P. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.174 · Cited by 103
Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway
Busso, C. S., Iwakuma, T., & Izumi, T. (2009) · Oncogene · doi:10.1038/onc.2009.5 · Cited by 100
Shema, E., Kim, J., Roeder, R. G., & Oren, M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.011 · Cited by 103
Self-citationRegulation of the p53 transcriptional activity
Liu, G., & Chen, X. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20700 · Cited by 100
Aylon, Y., Ofir-Rosenfeld, Y., Yabuta, N., Lapi, E., Nojima, H., Lü, X., & Oren, M. (2010) · Genes & Development · doi:10.1101/gad.1954410 · Cited by 100
Self-citationFåhræus, R., & Olivares‐Illana, V. (2013) · Oncogene · doi:10.1038/onc.2013.410 · Cited by 103
Shema, E., Nikolov, M., Haj‐Yahya, M., Siman, P., Allemand, E., Yamaguchi, Y., Muchardt, C., Urlaub, H., Brik, A., Oren, M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.014 · Cited by 94
Self-citationCooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing
Wu, X., Gong, Y., Yue, J., Qiang, B., Yuan, J., & Peng, X. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn243 · Cited by 94
The enigmatic role of H2Bub1 in cancer
Johnsen, S. A. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.002 · Cited by 90
RYBP stabilizes p53 by modulating MDM2
Chen, D., Zhang, J., Li, M., Rayburn, E. R., Wang, H., & Zhang, R. (2008) · EMBO Reports · doi:10.1038/embor.2008.231 · Cited by 89
Developing Targeted Therapies That Exploit Aberrant Histone Ubiquitination in Cancer
Jeusset, L. M., & McManus, K. J. (2019) · Cells · doi:10.3390/cells8020165 · Cited by 95
Muench, P., Probst, S., Schuetz, J., Leiprecht, N., Busch, M., Wesselborg, S., Stubenrauch, F., & Iftner, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1307 · Cited by 92
Stommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 90
Tyteca, S., Vandromme, M., Legube, G., Chevillard, M., & Trouche, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601066 · Cited by 91
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
Brekman, A., Singh, K. E., Polotskaia, A., Kundu, N., & Bargonetti, J. (2011) · Breast Cancer Research · doi:10.1186/bcr2804 · Cited by 87
Balance of Yin and Yang: Ubiquitylation-Mediated Regulation of p53 and c-Myc
Dai, M., Jin, Y., Gallegos, J. R., & Lu, H. (2006) · Neoplasia · doi:10.1593/neo.06334 · Cited by 85
Menendez, D., Inga, A., & Resnick, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2297-2308.2006 · Cited by 81
Ubiquitin–Proteasome System in Spermatogenesis
Bose, R., Manku, G., Culty, M., & Wing, S. S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0817-2_9 · Cited by 83
RNA content in the nucleolus alters p53 acetylation via MYBBP1A
Kuroda, T., Murayama, A., Katagiri, N., Ohta, Y., Fujita, E., Masumoto, H., Ema, M., Takahashi, S., Kimura, K., & Yanagisawa, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.23 · Cited by 77
Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity
Nomura, K., Klejnot, M., Kowalczyk, D., Hock, A. K., Sibbet, G. J., Vousden, K. H., & Huang, D. T. C. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3414 · Cited by 72
Aylon, Y., Yabuta, N., Besserglick, H., Buganim, Y., Rotter, V., Nojima, H., & Oren, M. (2009) · Oncogene · doi:10.1038/onc.2009.270 · Cited by 71
Self-citationBiochemical and Biophysical Characterization of a Chimeric TRIM21-TRIM5α Protein
Kar, A. K., Diaz‐Griffero, F., Li, Y., Li, X., & Sodroski, J. (2008) · Journal of Virology · doi:10.1128/jvi.01559-08 · Cited by 70
E3 Ligases Determine Ubiquitination Site and Conjugate Type by Enforcing Specificity on E2 Enzymes
David, Y., Ternette, N., Edelmann, M. J., Ziv, T., Gayer, B., Sertchook, R., Dadon, Y., Kessler, B. M., & Navon, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234559 · Cited by 72
Song, J., Ma, S., Luo, J., Zhang, H., Wang, R.-X., Liu, H., Li, L., Zhang, Z., & Zhou, R. (2018) · Oncology Reports · doi:10.3892/or.2018.6282 · Cited by 72
Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14ARF-MDM2-p53 axis
Maerken, T. V., Vandesompele, J., Rihani, A., Paepe, A. D., & Speleman, F. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.138 · Cited by 74
Histone Ubiquitylation and the Regulation of Transcription
Osley, M. A., Fleming, A. B., & Kao, C.-F. (2006) · Results and problems in cell differentiation · doi:10.1007/400_006 · Cited by 66
KE, Q., Ellen, T. P., & Costa, M. W. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.12.015 · Cited by 65
Jäger, W., Santag, S., Weidner-Glunde, M., Gellermann, E., Kati, S., Pietrek, M., Viejo‐Borbolla, A., & Schulz, T. F. (2012) · Journal of Virology · doi:10.1128/jvi.06840-11 · Cited by 67
Histone H2B ubiquitination: the cancer connectionPreprint
Espinosa, J. M. (2008) · Genes & Development · doi:10.1101/gad.1732108 · Cited by 68
Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication
Klusmann, I., Wohlberedt, K., Magerhans, A., Teloni, F., Korbel, J. O., Altmeyer, M., & Dobbelstein, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809592115 · Cited by 65
MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output
Chen, L., Li, Z., Zwolińska, A., Smith, M. A., Cross, B. L., Koomen, J. M., Yuan, Z.-M., Jenuwein, T., Marine, J., Wright, K. L., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.140 · Cited by 62
Histone monoubiquitination by Clock-Bmal1 complex marks Per1 and Per2 genes for circadian feedback
Tamayo, A. G., Duong, H. A., Robles, M. S., Mann, M., & Weitz, C. J. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3076 · Cited by 60
Mdm2 in growth signaling and cancer
Levav-Cohen, Y., Haupt, S., & Haupt, Y. (2005) · Growth Factors · doi:10.1080/08977190500196218 · Cited by 60
The p53-mediated cytotoxicity of photodynamic therapy of cancer: Recent advances
Zawacka‐Pankau, J., Krachulec, J., Grulkowski, I., Bielawski, K. P., & Selivanova, G. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.07.012 · Cited by 62
RNA-binding E3 ubiquitin ligases: novel players in nucleic acid regulation
Cano, F., Miranda‐Saavedra, D., & Lehner, P. J. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381621 · Cited by 56
Yan, B., Yang, X., Lee, T., Friedman, J., Tang, J., Waes, C. V., & Chen, Z. (2007) · Genome biology · doi:10.1186/gb-2007-8-5-r78 · Cited by 56
Mdm2 and MdmX as Regulators of Gene Expression
Biderman, L., Manley, J. L., & Prives, C. L. (2012) · Genes & Cancer · doi:10.1177/1947601912455331 · Cited by 58
Mungamuri, S. K., Qiao, R. F., Yao, S., Manfredi, J. J., Gu, W., & Aaronson, S. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.049 · Cited by 54
Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1
Sun, X. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.75 · Cited by 56
Histone Monoubiquitination in Chromatin Remodelling: Focus on the Histone H2B Interactome and Cancer
Marsh, D. J., Ma, Y., & Dickson, K.-A. (2020) · Cancers · doi:10.3390/cancers12113462 · Cited by 54
Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy
Allende-Vega, N., & Saville, M. K. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.10.004 · Cited by 51
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Li, M., & Gu, W. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.020 · Cited by 54
Targeting the MDM2/MDM4 Interaction Interface as a Promising Approach for p53 Reactivation Therapy
Pellegrino, M., Mancini, F., Lucà, R., Coletti, A., Giacchè, N., Manni, I., Arisi, I., Florenzano, F., Teveroni, E., Buttarelli, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0439 · Cited by 49
Mechanistic Studies of MDM2-mediated Ubiquitination in p53 Regulation
Brooks, C. L., Li, M., & Gu, W. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700961200 · Cited by 48
Ohkubo, S., Tanaka, T., Taya, Y., Kitazato, K., & Prives, C. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601388200 · Cited by 47
Control of Cell Proliferation and Growth by Myc Proteins
Bernard, S., & Eilers, M. (2006) · Springer eBooks · doi:10.1007/400_004 · Cited by 48
Wienken, M., Moll, U. M., & Dobbelstein, M. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw046 · Cited by 44
Writing Histone Monoubiquitination in Human Malignancy—The Role of RING Finger E3 Ubiquitin Ligases
Marsh, D. J., & Dickson, K.-A. (2019) · Genes · doi:10.3390/genes10010067 · Cited by 44
Yu, Z.-C., Huang, Y., & Shieh, S.-Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1173 · Cited by 44
Wilkinson, D. S., Tsai, W.-W., Schumacher, M. A., & Barton, M. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01442-07 · Cited by 45
USP7/HAUSP stimulates repair of oxidative DNA lesions
Khoronenkova, S. V., Dianova, I. I., Parsons, J. L., & Dianov, G. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1210 · Cited by 40
MDM2 and MDMX in Cancer and Development
Marine, J. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00003-6 · Cited by 39
Epigenetic modification and a role for the E3 ligase RNF40 in cancer development and metastasis
Fu, J., Liao, L., Balaji, K. S., Wei, C., Kim, J., & Peng, J. (2020) · Oncogene · doi:10.1038/s41388-020-01556-w · Cited by 40
MEL-18 loss mediates estrogen receptor–α downregulation and hormone independence
Lee, J., Won, H., Park, J., Kim, H., Choi, H., Shin, D., Kang, J., Woo, J. K., Oh, S.-H., Son, T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73743 · Cited by 36
Splicing Up Mdm2 for Cancer Proteome Diversity
Okoro, D. R., Rosso, M., & Bargonetti, J. (2012) · Genes & Cancer · doi:10.1177/1947601912455323 · Cited by 36
Metadata
- Authors
- Minsky, N., & Oren, M.
- Affiliations
- Weizmann Institute of Science (IL)
- Corresponding author
- Oren, Moshe
- ORCID
- Oren, Moshe
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 16
- Issue
- 4
- Pages
- 631-639
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W1999310200
- Cited by
- 204
- References
- 54
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 8 · 2019: 13 · 2018: 6 · 2017: 1 · 2016: 7 · 2015: 13 · 2014: 10 · 2013: 5 · 2012: 12
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R37 CA40099, R37CA040099)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- MDM2, RING domain, E3 ubiquitin ligase, histone ubiquitination, histone H2A, transcriptional repression, p53, chromatin, gene silencing, oncogenic activity
- MeSH terms
- Cell Line, Chromatin, Glutathione Transferase, Histones, Humans, Luciferases, Nuclear Proteins, Precipitin Tests, Promoter Regions, Genetic, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transcription, Genetic, Ubiquitins, Gene Expression Regulation, Neoplastic, Genes, Reporter, Cell Line, Tumor, Chromatin Immunoprecipitation, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review